Request Proposal

Advancing Global Clinical Trials with Precision and Integrity in Pakistan

VisolePakistan bridges the gap between global pharmaceutical innovation and Pakistan’s vast patient populations. We deliver fully compliant clinical research services with speed, accuracy, and local expertise

Submit an RFP
Our Services

Why Conduct Clinical Trials in Pakistan?

Pakistan is rapidly becoming a preferred global hub for clinical development. VisolePakistan helps international pharmaceutical companies leverage these unique regional strengths to accelerate drug development timelines

Massive Patient Access

Direct connection to a population of over 240 million with centralized hospitals, making patient recruitment incredibly fast.

Expert Medical Doctors

Collaborations with top-tier, English-speaking medical investigators trained in international research standards

Cost-Effective Operations

High-quality data and trial execution at a fraction of Western operational cost

Treatment-Nau00efve Patients:

Access to patients who have not yet received advanced therapies, providing clean and highly accurate medical data

End-to-End Clinical Research Solutions

Clinical Trial Management

Complete oversight of Phase Iu2013IV human trials, ensuring they finish on time and within budget.

Regulatory Affairs

Expert, fast-tracked handling of approvals with the Drug Regulatory Authority of Pakistan (DRAP)

Site Monitoring

Rigorous on-the-ground auditing by our team to guarantee 100% data accuracy and patient safety.

FAQs

Why should a global pharmaceutical sponsor choose Pakistan for clinical trials?

Pakistan offers a rare combination of a massive, treatment-naïve patient population (over 240 million) and a highly centralized hospital network. This allows for incredibly rapid patient recruitment timelines compared to Western regions. Additionally, trials are conducted by highly qualified, English-speaking medical investigators at a fraction of Western operational costs.

Clinical trial approvals are governed by the Drug Regulatory Authority of Pakistan (DRAP). Visole Pakistan specializes in fast-tracking this process. While timelines can vary based on the trial phase and therapeutic complexity, standard regulatory and ethical committee approvals typically take between 8 to 12 weeks from submission to approval

Compliance is our highest priority. All clinical operations executed by Visole Pakistan strictly adhere to ICH-GCP guidelines, the Declaration of Helsinki, and local DRAP regulations. Our clinical research associates (CRAs) conduct rigorous, regular on-site monitoring and source data verification (SDV) to guarantee 100% audit-ready data accuracy

Thanks to our extensive network of top-tier medical institutions, we support a broad spectrum of therapeutic fields. Our core areas of expertise include Oncology, Cardiology, Diabetology/Metabolic Disorders, Infectious Diseases, Gastroenterology, and Pediatrics.

We understand that sponsor timelines are tight. We leverage our existing network of pre-vetted investigator sites to deliver comprehensive local protocol feasibility assessments and patient population estimates within 5 to 7 business days of receiving your core protocol layout.

You can click the “Submit an RFP” button on our website to share your basic study parameters. Alternatively, you can email our business development team directly at info@visolepakistan.com with your protocol synopsis. A dedicated project lead will get in touch with you within 24 hours.